市場調查報告書
商品編碼
1446236
2024-2028年家庭輸液治療的全球市場Global Home Infusion Therapy Market 2024-2028 |
2023-2028年家庭輸液治療市場預估為173.7億美元,預測期內複合年增率為8.12%。
該報告包括對家庭輸液治療市場的總體分析、市場規模/預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。
它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括輸液幫浦和遠端監控設備的技術進步、慢性病盛行率的增加以及全球老年人口需要長期醫療照護的成長。
市場範圍 | |
---|---|
基準年 | 2024年 |
結束年份 | 2028年 |
預測期 | 2024-2028 |
成長動力 | 加速度 |
2024年與前一年同期比較 | 7.58% |
複合年成長率 | 8.12% |
增量 | 173.7億美元 |
研究指出,患者照護和治療選擇方面的發展和合作的增加是推動未來幾年家庭輸液治療市場成長的關鍵因素之一。此外,對專業藥房服務與家庭輸液治療提供的服務相結合的需求不斷成長,以及家庭輸液專業醫療保健專業人員數量的增加也將導致巨大的市場需求。
The home infusion therapy market is forecasted to grow by USD 17.37 bn during 2023-2028, accelerating at a CAGR of 8.12% during the forecast period. The report on the home infusion therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in infusion pumps and remote monitoring devices, increasing prevalence of chronic diseases, and growing geriatric population worldwide requiring long-term medical care.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 7.58% |
CAGR | 8.12% |
Incremental Value | $17.37bn |
Technavio's home infusion therapy market is segmented as below:
By Application
By Product
By Geographical Landscape
This study identifies the increasing developments and collaborations for patient care and therapeutic options as one of the prime reasons driving the home infusion therapy market growth during the next few years. Also, expanding demand for specialty pharmacy services integrated with home infusion therapy offerings and rising initiations on specialized healthcare professionals for home infusion will lead to sizable demand in the market.
The report on the home infusion therapy market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading home infusion therapy market vendors that include B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Bio-Med Pvt. Ltd., Cardinal Health Inc., Catholic Health Initiatives, Community Surgical Supply, Fresenius SE and Co. KGaA, Health Vista Pvt Ltd., Health2home, ICU Medical Inc., Medix Infusion, Nipro Corp., Option Care Health Inc., Prochant, Reviv Genetics Ltd., Sober Care Surgical, UnitedHealth Group Inc., University of Pennsylvania Health System, and Walgreens Boots Alliance Inc.. Also, the home infusion therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: